Delivery of the p38 MAPkinase inhibitor SB202190 to angiogenic endothelial cells: development of novel RGD-equipped and PEGylated drug-albumin conjugates using platinum(II)-based drug linker technology
DSpace/Manakin Repository
Delivery of the p38 MAPkinase inhibitor SB202190 to angiogenic endothelial cells: development of novel RGD-equipped and PEGylated drug-albumin conjugates using platinum(II)-based drug linker technology
Temming, K.; Lacombe, M.; van der Hoeven, P.; Pradash, J.; Gonzalo, T.; Dijkers, E.C.F.; Orfi, L.; Keri, G.; Poelstra, K.; Molema, G.; Kok, R.J.
(2006) Bioconjugate Chemistry, volume 17, pp. 1246 - 1255